HALO — Halozyme Therapeutics Inc
In 2026 Q2, 5 of the 140 tracked hedge funds reported a position in Halozyme Therapeutics Inc (HALO), worth $53.37M combined. Over the quarter 2 opened or added, 4 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $37.54M | 0.05% | -34.5% |
| Panoramic | $9.11M | 3.90% | NO CHANGE |
| Augustine | $4.83M | 0.98% | NEW |
| Quadrature | $1.03M | 0.00% | NEW |
| VanEck | $856.66K | 0.00% | -0.1% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.